Shares of Relx Plc (NYSE:RELX – Get Free Report) have received an average recommendation of “Buy” from the five analysts that are covering the company, MarketBeat reports. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company.
A number of equities research analysts have recently commented on the stock. The Goldman Sachs Group assumed coverage on shares of Relx in a research report on Wednesday, March 26th. They issued a “buy” rating for the company. Redburn Atlantic began coverage on Relx in a report on Wednesday, January 8th. They issued a “buy” rating for the company. Morgan Stanley reissued an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th. StockNews.com lowered Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. Finally, Barclays raised shares of Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th.
Read Our Latest Research Report on RELX
Institutional Investors Weigh In On Relx
Relx Stock Down 0.1 %
Shares of RELX opened at $52.16 on Thursday. The stock has a 50 day moving average price of $49.39 and a 200 day moving average price of $48.06. Relx has a one year low of $40.25 and a one year high of $52.55. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The stock has a market capitalization of $96.54 billion, a price-to-earnings ratio of 28.04, a PEG ratio of 2.73 and a beta of 0.84.
Relx Increases Dividend
The business also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be given a $0.5586 dividend. The ex-dividend date is Friday, May 9th. This represents a yield of 1.6%. This is a boost from Relx’s previous semi-annual dividend of $0.23. Relx’s dividend payout ratio is presently 59.68%.
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
- Five stocks we like better than Relx
- 3 Small Caps With Big Return Potential
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- 3 Dividend Kings To Consider
- Why Call Option Traders Are Targeting This Dividend ETF Now
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.